– Preclinical data demonstrated PALI-2108 to be safe and well tolerated – PALI-2108 is orally delivered and colon activated allowing for local activity.
Palisade Bio Inc. (PALI) Reports Positive Preclinical Data of PALI-2108 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Palisade Bio, Inc. (PALI) saw a 88% increase in its stock on Monday following the announcement of positive preclinical data for its main asset, PALI-2108, at the Crohn's & Colitis Congress on January 25-27, 2024.
Wrapped up for the holidays aims to keep vulnerable residents warm paherald.sk.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from paherald.sk.ca Daily Mail and Mail on Sunday newspapers.